PRJ2203: Dolutegravir Post Authorization Safety Study (PASS)

Clinical trial NCT03327740 · COMPLETED

Trial details

NCT number: NCT03327740
Sponsor: ViiV Healthcare
Status: COMPLETED
Study type: OBSERVATIONAL

Infection, Human Immunodeficiency Virus I

Start date: 2014-09-30
Primary completion: 2019-12-31
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.